Poxel S.A. (OTCMKTS:PXXLF) Sees Large Increase in Short Interest

Poxel S.A. (OTCMKTS:PXXLF) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 9,400 shares, an increase of 9,300.0% from the January 31st total of 100 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Poxel Stock Performance

Shares of OTCMKTS:PXXLF opened at $0.25 on Friday. Poxel has a 1 year low of $0.25 and a 1 year high of $0.25. The business has a fifty day simple moving average of $0.25 and a 200 day simple moving average of $0.48.

About Poxel

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.